Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Antiparasitic Drugs Market’s Growth Trajectory From 2025 To 2034?
The market size of antiparasitic drugs has seen a strong surge in recent times. It is projected to expand from $24.06 billion in 2024 to $25.58 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.3%. The growth seen in the historic period is a result of an increased incidence of parasitic infections, resilience to prevailing treatments, and worldwide health initiatives.
Over the coming years, the antiparasitic drugs market is forecasted to witness a robust increase in its size. It is predicted to reach a value of $33.29 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.8%. The escalation in the forthcoming period can be credited to the rise of new parasitic dangers, climate change, vector-borne diseases, and a heightened global emphasis on health security and healthcare accessibility. The forthcoming period anticipates a surge in trends such as advancements in the development of drugs, targeted treatments, combination therapies, collaborations between private and public sectors, telemedicine, and remote diagnostics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp
What Are the Core Growth Drivers Propelling the Antiparasitic Drugs Market Forward?
Growth in the antiparasitic drugs market is anticipated to be driven by the escalating occurrence of vector-borne diseases. These infectious maladies, which include malaria, dengue, and yellow fever, are transmitted to humans or other animals by arthropods, predominantly mosquitoes, ticks, and flies. Antiparasitic medications are instrumental in thwarting the transmission of these diseases, as they eliminate the parasites responsible. Malaria, for example, is often treated with antiparasitic drugs like chloroquine, doxycycline, and atovaquone-proguanil. An illustration of the escalating infection rates is seen in data from the US Centers for Disease Control and Prevention in June 2024, revealing that over 9.7 million dengue cases were recorded across the Americas between January to June 2024, more than doubling the 4.6 million cases reported in 2023. Furthermore, Puerto Rico reported 1,498 dengue cases in the United States, with an additional 745 cases detected among U.S. travelers returning from affected regions. Consequently, this rising prevalence of vector-borne diseases is stimulating the growth of the antiparasitic drugs market.
What Segment Types Define the Antiparasitic Drugs Market Structure?
The antiparasitic drugs market covered in this report is segmented –
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Antiparasitic Drugs Market?
North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Emerging Trends that Are Influencing theAntiparasitic Drugs Industry Evolution?
Key players in the antiparasitic drugs market are prioritizing the creation of innovative solutions such as chewable veterinary drugs to boost ease of use and enhance pet adherence. Chewable veterinary drugs are tasty, simple to administer tablets or treats specifically created to deliver medication to pets. They improve pet adherence by making the treatment more enjoyable and less stressful. For instance, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a pharmaceutical company based in Germany, rolled out NexGard Spectra for comprehensive parasite regulation. NexGard SPECTRA is a soft, chewable treat with a pleasing flavor that provides an all-round internal and external parasite control for dogs, effectively combating fleas, ticks, heartworms, and various intestinal worms in just a single monthly dosage. It shows fast action by eliminating fleas within four hours after administration and reaches over 99% effectiveness against multiple parasites shortly after.
View the full report here:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
What Is the Definition of the Antiparasitic Drugs Market?
Antiparasitic drugs are medications used to treat infections caused by various parasites that can infect humans, animals, or plants. Parasites are organisms that live on or within a host organism and derive their nutrients from it, often causing harm to the host in the process. Antiparasitic drugs target these parasites to either kill them or inhibit their growth.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12927
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model